Prospective Observational Single Arm Open-Label Multicenter Study to Assess the Safety, Tolerability and Efficacy of ellaOne (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Adult Women.

Trial Profile

Prospective Observational Single Arm Open-Label Multicenter Study to Assess the Safety, Tolerability and Efficacy of ellaOne (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Adult Women.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 May 2014

At a glance

  • Drugs Ulipristal (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions
  • Sponsors HRA Pharma
  • Most Recent Events

    • 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 22 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top